C. Fabères

940 total citations
30 papers, 709 citations indexed

About

C. Fabères is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, C. Fabères has authored 30 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 11 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in C. Fabères's work include Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Hematopoietic Stem Cell Transplantation (9 papers). C. Fabères is often cited by papers focused on Chronic Myeloid Leukemia Treatments (18 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Hematopoietic Stem Cell Transplantation (9 papers). C. Fabères collaborates with scholars based in France and Brazil. C. Fabères's co-authors include Gérald Marit, Josy Reiffers, Pascale Cony‐Makhoul, Marion Montastruc, C Bilhou-Nabéra, A Broustet, J.-M. Boiron, Arnaud Pigneux, G Vezon and Ph. Bernard and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stem Cells.

In The Last Decade

C. Fabères

29 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Fabères France 15 625 296 170 150 128 30 709
G Meloni Italy 11 461 0.7× 268 0.9× 118 0.7× 80 0.5× 99 0.8× 24 547
Jerry Radich United States 11 518 0.8× 248 0.8× 111 0.7× 76 0.5× 168 1.3× 29 602
K. H. Th'ng United Kingdom 14 458 0.7× 270 0.9× 102 0.6× 97 0.6× 99 0.8× 19 622
M Shtalrid Israel 12 309 0.5× 213 0.7× 81 0.5× 67 0.4× 78 0.6× 28 461
Hagop M. Kantarjian United States 11 437 0.7× 256 0.9× 78 0.5× 157 1.0× 318 2.5× 17 650
Pierre Hirsch France 15 294 0.5× 158 0.5× 100 0.6× 143 1.0× 86 0.7× 39 568
Gerlinde Mitterbauer‐Hohendanner Austria 10 327 0.5× 215 0.7× 156 0.9× 99 0.7× 36 0.3× 20 530
Salman Fazal United States 12 394 0.6× 320 1.1× 121 0.7× 140 0.9× 46 0.4× 51 653
Eaves Ac Canada 11 413 0.7× 207 0.7× 51 0.3× 85 0.6× 56 0.4× 18 513
Bjarne Anker Jensen Denmark 10 460 0.7× 217 0.7× 63 0.4× 69 0.5× 54 0.4× 11 638

Countries citing papers authored by C. Fabères

Since Specialization
Citations

This map shows the geographic impact of C. Fabères's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Fabères with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Fabères more than expected).

Fields of papers citing papers by C. Fabères

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Fabères. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Fabères. The network helps show where C. Fabères may publish in the future.

Co-authorship network of co-authors of C. Fabères

This figure shows the co-authorship network connecting the top 25 collaborators of C. Fabères. A scholar is included among the top collaborators of C. Fabères based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Fabères. C. Fabères is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vergniol, J., Sébastien Duc, Guangdong Hou, et al.. (2016). Sexual quality of life is impaired in patients with chronic hepatitis C. International Journal of Impotence Research. 28(2). 68–73. 12 indexed citations
2.
Mahon, F.-X., X. Delbrel, Pascale Cony‐Makhoul, et al.. (2002). Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa. Journal of Clinical Oncology. 20(1). 214–220. 52 indexed citations
3.
Jourdan, Éric, Josy Reiffers, Anne Marie Stoppa, et al.. (2001). Outcome of Adult Patients with Acute Myeloid Leukemia who Failed to Achieve Complete Remission after one Course of Induction Chemotherapy: A Report from the BGMT Study Group: For the BGMT. Leukemia & lymphoma. 42(1-2). 57–65. 10 indexed citations
4.
Boiron, Jean-Michel, Arnaud Pigneux, C. Fabères, et al.. (2001). Allogeneic Transplantation for Patients with Advanced Acute Leukemia: a Single Center Retrospective Study of 92 Patients. Leukemia & lymphoma. 41(3-4). 285–296. 9 indexed citations
5.
Barthe, Christophe, François‐Xavier Mahon, C. Fabères, et al.. (2001). Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α–treated chronic myeloid leukemia. Blood. 97(11). 3568–3573. 16 indexed citations
6.
Pigneux, Arnaud, C. Fabères, JM Boiron, et al.. (1999). Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience. Bone Marrow Transplantation. 24(3). 265–270. 8 indexed citations
7.
8.
9.
Mahon, F.-X., C. Fabères, Sophie Pueyo, et al.. (1998). Response at Three Months Is a Good Predictive Factor for Newly Diagnosed Chronic Myeloid Leukemia Patients Treated by Recombinant Interferon-. Blood. 92(11). 4059–4065. 46 indexed citations
10.
Marit, Gérald, C. Fabères, J L Pico, et al.. (1996). Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.. Journal of Clinical Oncology. 14(4). 1306–1313. 26 indexed citations
11.
Marit, Gérald, C. Fabères, Jean-Michel Boiron, et al.. (1996). Autologous blood progenitor cell transplantation in high-risk multiple myeloma. Stem Cells. 13(S2). 160–163. 1 indexed citations
12.
Fabères, C., Marion Montastruc, Gérald Marit, et al.. (1996). High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia.. PubMed. 17 Suppl 3. S33–7. 5 indexed citations
13.
Reiffers, Josy, C. Fabères, JM Boiron, et al.. (1994). Peripheral Blood Progenitor Cell Transplantation in 118 Patients with Hematological Malignancies: Analysis of Factors Affecting the Rate of Engraftment. Journal of Hematotherapy. 3(3). 185–191. 42 indexed citations
14.
Boiron, JM, Françis Belloc, Marion Montastruc, et al.. (1994). Daunorubicin (DNR) Accumulation in Fresh Leukemic Cells: Correlation with Clinical and Biological Features. Leukemia & lymphoma. 13(3-4). 291–296. 2 indexed citations
15.
Reiffers, Josy, et al.. (1994). Autologous transplantation in chronic myelogenous leukemia: European results: Chronic Leukemia Working Party of the EBMT.. PubMed. 14 Suppl 3. S51–4. 5 indexed citations
16.
Reiffers, Josy, Marion Montastruc, Gérald Marit, et al.. (1993). Autologous Blood Stem Cell Transplantation Followed by Recombinant Alpha Interferon as Treatment for Patients with High-Risk Chronic Myelogenous Leukemia. A Report of 32 Cases. Leukemia & lymphoma. 11(sup1). 297–299. 3 indexed citations
17.
Reiffers, Josy, J Cahn, Marion Montastruc, et al.. (1993). Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: Preliminary results. Stem Cells. 11(S3). 23–24. 6 indexed citations
18.
Montastruc, Marion, J Cahn, G Souillet, et al.. (1993). Autologous blood stem-cell transplantation and recombinant interferon alfa in chronic myeloid leukemia.. PubMed. 30(3 Suppl 3). 51–2. 5 indexed citations
19.
Cowen, D., Pierre Richaud, Gérald Marit, et al.. (1992). Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique.. PubMed. 10(6). 515–9. 8 indexed citations
20.
Reiffers, Josy, R. Trouette, Gérald Marit, et al.. (1991). Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. British Journal of Haematology. 77(3). 339–345. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Meloni Breakdown of academic impact, for papers by Jerry Radich Breakdown of academic impact, for papers by K. H. Th'ng Breakdown of academic impact, for papers by M Shtalrid Breakdown of academic impact, for papers by Hagop M. Kantarjian Breakdown of academic impact, for papers by Pierre Hirsch Breakdown of academic impact, for papers by Gerlinde Mitterbauer‐Hohendanner Breakdown of academic impact, for papers by Salman Fazal Breakdown of academic impact, for papers by Eaves Ac Breakdown of academic impact, for papers by Bjarne Anker Jensen
Rankless by CCL
2026